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Abstract
Mutation of the tumor suppressor adenomatous polyposis coli (APC) is considered an initiating 
step in the genesis of the vast majority of colorectal cancers. APC inhibits the Wnt signaling 
pathway by targeting proto-oncogene β-catenin for destruction by cytoplasmic proteasomes. In the 
presence of a Wnt signal, or in the absence of functional APC, β-catenin can serve as a 
transcription co-factor for genes required for cell proliferation such as cyclin D1 and c-Myc. In 
cultured cells, APC shuttles between the nucleus and cytoplasm, with nuclear APC implicated in 
inhibition of Wnt target gene expression. Taking a genetic approach to evaluate the functions of 
nuclear APC in the context of a whole organism, we generated a mouse model with mutations that 
inactivate the nuclear localization signals of Apc (ApcmNLS). ApcmNLS/mNLS mice are viable and 
fractionation of embryonic fibroblasts (MEFs) isolated from these mice revealed a significant 
reduction in nuclear Apc compared to Apc+/+ MEFs. The levels of Apc and β-catenin protein were 
not significantly altered in small intestinal epithelia from ApcmNLS/mNLS mice. Compared to 
Apc+/+ mice, ApcmNLS/mNLS mice displayed increased proliferation in epithelial cells from the 
jejunum, ileum, and colon. These same tissues from ApcmNLS/mNLS mice displayed more mRNA 
from three genes up-regulated in response to canonical Wnt signal, c-Myc, Axin2, and Cyclin D1, 
and less mRNA from Hath 1 which is down-regulated in response to Wnt. These observations 
suggest a role for nuclear Apc in inhibition of canonical Wnt signaling and control of epithelial 
proliferation in intestinal tissue. Furthermore, we found ApcMin/+ mice, which harbor a mutation 
that truncates Apc, have increased polyp size and multiplicity if they also carry the ApcmNLS 
allele. Taken together, this analysis of the novel ApcmNLS mouse model supports a role for nuclear 
Apc in control of Wnt target genes, intestinal epithelial cell proliferation and polyp formation.
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The tumor suppressor protein adenomatous polyposis coli (APC) is large, with multiple 
subcellular localizations and functions. Mutation of the APC gene is considered the initiating 
event in the formation of most intestinal polyps, the precursors to colorectal cancer (21, 22, 
44). As such, an intense investigation of potential APC functions involved in tumor 
suppression has led to identification of APC as a Wnt signaling pathway antagonist (10). In 
this capacity, APC is part of a cytoplasmic protein complex that targets the proto-
oncoprotein β-catenin for proteasome-mediated destruction (25). APC has also been 
observed in nuclei of cultured colon cells and colonic epithelia from human tissue using 
conventional and confocal immunofluorescent microscopy and immunoelectron microscopy 
(1, 31, 42). Nuclear APC has three proposed roles in regulating Wnt signaling. First, nuclear 
APC binds to nuclear β-catenin and likely competes with transcription factor TCF/LEF for 
β-catenin binding (32). Second, nuclear APC has been implicated in the nuclear export of β-
catenin (13, 33, 39). Finally, the interaction of nuclear APC with transcriptional corepressor 
CtBP further contributes to the modulation of Wnt signaling (43). In addition to its role as a 
repressor of β-catenin, nuclear APC has been implicated in DNA synthesis and repair (15, 
37).
Because APC is a large protein (~310 kDa), it is unable to simply diffuse into the nucleus 
but must instead be actively transported through nuclear pores (20, 35). Several domains of 
APC have been proposed to mediate this nuclear entry, including two monopartite nuclear 
localization signals (NLS) in the central part of the protein (51), as well as an armadillo 
repeat region closer to the N-terminus (9). In addition, phosphorylation of APC regulates its 
localization (51) and relative levels of nuclear and cytoplasmic APC appear to correlate with 
the proliferative status of a cell (52).
Although many mouse models have been generated with alterations in Apc, they either 
produce no Apc protein (3), full-length Apc at a reduced level (14), or a truncated Apc (4, 7, 
16, 24, 34, 41, 45). Elimination of the C-terminal portion of Apc leads to at least partial loss 
of function and mice homozygous for mutations that truncate Apc typically do not develop 
beyond embryonic day 8 (46). To date, no mouse model with targeted disruption of the two 
Apc NLSs has been generated.
To assess the functions of nuclear Apc in the context of a whole organism, we introduced 
germline mutations into the mouse Apc gene that result in inactivation of the two 
characterized Apc NLSs (ApcmNLS). Inactivation of the two APC NLSs was previously 
shown to attenuate the ability of full-length exogenous human APC to enter the nucleus 
(51). In the present study, mice heterozygous (ApcmNLS/+)or homozygous (ApcmNLS/mNLS) 
for mutant Apc NLS were viable. Intestinal epithelial cells in ApcmNLS/mNLS mice showed 
increased levels of Wnt target gene expression and more proliferation compared to their 
wild-type littermates. For the past two decades, the ApcMin/+ mouse has been a popular 
model organism to study Apc mutation-driven tumorigenesis (23). ApcMin/+ mice have a 
missense mutation in Apc that results in truncation of the C-terminal 2/3 of the protein. 
ApcMin/+ mice develop 20–60 intestinal polyps at the time of their natural death, ~120 days 
of age. We found that ApcMin/mNLS mice displayed significantly more intestinal polyps than 
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ApcMin/+ mice and these polyps were larger. Together, these results suggest that nuclear Apc 
participates in regulation of Wnt signaling, proliferation and tumor suppression.
Results
Mutation of two Apc NLSs in ES cells and generation of mutant mice
To introduce specific mutations that inactivate both Apc NLSs in mouse embryonic stem 
(ES) cells and ultimately generate ApcmNLS/mNLS mice, we constructed a gene-targeting 
vector (Figure 1A). The targeted mutations alter a total of six amino acids in Apc, four in 
NLS1 and two in NLS2 (Figure 1B). These mutations substitute a neutral alanine for the 
basic lysine residues in the mono-partite NLSs and have been shown to inhibit nuclear 
import of exogenously expressed APC (51). Each NLS is adjacent to a SAMP repeat region 
(so named because they each contain a central Ser-Ala-Met-Pro) which is involved in APC 
binding to axin. However, mutation of both NLSs does not appear to interfere with axin 
binding as full-length APC with mutations in both NLSs still interacts with axin 
(Supplemental Fig. 1). These mutations also establish two novel restriction sites, Sst II in 
NLS1 and Eag I in NLS2 which were utilized for screening purposes (Figure 1B). The 
targeting vector contains an 11.5 kb genomic Nhe I/ Not I fragment encompassing exons 14 
and 15 of Apc as well as the surrounding introns. The entire Apc region of the vector was 
validated by sequencing. The positive selection marker contained in a germline-induced 
self-excision cassette was placed in the intron following Apc exon 15 (2). In mice, the tACE 
promoter initiates transcription of Cre-recombinase during spermatogenesis, inducing Cre-
mediated self-excision of the selectable Neor marker in the germline of the transgenic 
animals. Following self-excision, only one 34 bp minimal LoxP element remains in the last 
Apc intron. The targeting construct also contains a copy of the herpes simplex virus 
thymidine kinase gene (TkHSV) to allow negative selection of homologous recombinant ES 
clones.
Identification of homologous recombinant ES clones was accomplished using PCR with 
different primer pairs inside and outside the targeting construct. Of the 161 ES cell clones 
that survived positive and negative selection, 107 contained Apc with both mutant NLSs 
(Fig. 1C, 1D). Eight of these ES cell clones were identified as homologous recombinants by 
PCR to verify correct insertion of the 3’ region of the vector (Fig. 1F, 1H). Two were further 
analyzed by PCR and then subjected to restriction digestion in order to verify correct 
insertion of the 5’ region of the vector and to confirm that both mutant NLSs were integrated 
(Fig. 1F, 1G). One ES line with normal karyotype in 75% of the 50 cells analyzed was used 
for the initial blastocyst injections. From these injections, 11 chimeric mice, 4 females and 7 
males, were obtained; 3 males showed evidence of germline transmission when bred with 
wild-type C57BL/6J mice.
Elimination of the Neor/Cre selection cassette in ApcmNLS/+ mice
In the Apc1638N mouse model, a Neor selection gene inserted in exon 15 of Apc resulted in a 
dramatic decrease in the expression of the mutant Apc (7, 18). Thus it was critical to ensure 
that the Neor gene was excised from the ApcmNLS/+ mice. Excision of the Neor cassette in 
animals was verified by PCR analysis using oligos within the Neor/Cre selection cassette to 
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prime DNA amplification of genomic DNA isolated from ApcmNLS/+ mice in the N1 and N2 
generations (Figure 1E).
ApcmNLS/mNLS mice are viable
Many of the previously generated Apc mouse models display early embryonic lethality as 
homozygous mutants. When ApcmNLS/+ mice were interbred, both ApcmNLS/+ and 
ApcmNLS/mNLS mice were obtained. Thus, the two characterized monopartite nuclear 
localization signals of Apc are not essential for viability. ApcmNLS/mNLS mice showed no 
obvious growth defects compared to their wild-type littermates in generations N1-N13. 
ApcmNLS/mNLS mice are fertile, giving birth to litters of typical size. A long term survival 
analysis of 55 progeny from first generation ApcmNLS/+ females bred to first generation 
ApcmNLS/+ males revealed no significant difference in mouse survival between 
ApcmNLS/mNLS and Apc+/+ mice (data not shown). Thus, it appears that mutation of Apc 
NLS sequence has limited impact on the lifespan of the mice.
Reduced nuclear Apc in embryonic fibroblasts isolated from ApcmNLS/mNLS mice
Because of complications associated with fractionation of cells obtained from intestinal 
tissue, we used mouse embryonic fibroblasts (MEFs) isolated from congenic (generation 
N11) mice to determine effects of ApcmNLS on subcellular Apc localization (Fig. 2A). In 
Apc+/+ MEFs, more than one-third of the total Apc was associated with the nuclear fraction 
(Fig. 2B). ApcmNLS/mNLS MEFs were significantly compromised for nuclear Apc 
distribution, with eleven percent of the total Apc associated with the nuclear fraction. 
ApcmNLS/+ MEFs showed an intermediate phenotype, but nuclear Apc was not significantly 
different from that in Apc+/+ MEFs. β-catenin distribution was similar in all MEF lines (Fig. 
2C). Moreover, β-catenin appeared predominantly at cell-cell junctions in intestinal tissue 
from Apc+/+, ApcmNLS/+ and ApcmNLS/mNLS mice as assessed by immunohistochemistry 
(Supplemental Fig. 2A). A few crypts showed limited nuclear β-catenin staining in cells near 
their base, but this was consistent for all mouse genotypes (Supplemental Fig. 2B).
Apc and β-catenin levels in intestinal tissue
To determine if the single Lox P site remaining in the last Apc intron impacts Apc level in 
ApcmNLS mice, we measured the relative amount of Apc in whole cell protein lysates 
prepared from epithelial cells isolated from mouse jejunum, ileum and colon (Fig. 3). The 
Apc level did not vary significantly in epithelia from jejunum or ileum tissue isolated from 
ApcmNLS/mNLS, ApcmNLS/+ and Apc+/+ mice. Unexpectedly, colon epithelia from 
ApcmNLS/mNLS mice had higher levels of Apc than colon epithelia from Apc+/+ mice. 
Because Apc targets proto-oncoprotein β-catenin for destruction, higher Apc levels would be 
expected to result in reduced β-catenin levels. Unexpectedly, colon tissue from 
ApcmNLS/mNLS mice showed higher levels of β-catenin than colon tissue from Apc+/+ mice. 
In the small intestine, β-catenin levels were not altered in ApcmNLS/mNLS mice compared to 
Apc+/+ mice.
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Increased expression of Wnt targets in intestinal epithelia of ApcmNLS/mNLS mice
Based on previous studies performed in cultured cells, we proposed that nuclear APC binds 
nuclear β-catenin and sequesters it from transcription factor TCF/LEF. Consequently, Wnt 
target genes activated by the β-catenin/TCF/LEF complex are down-regulated by nuclear 
APC (33). Thus we predicted that cells defective in nuclear Apc would be less able to 
dampen Wnt target gene expression. To test this prediction, mRNA isolated from intestinal 
epithelial cells was evaluated for relative expression of various Wnt-regulated genes (Figure 
4). Three genes typically up-regulated in response to a canonical Wnt signal, c-Myc, Axin2, 
and Cyclin D1 showed higher expression throughout the intestinal epithelia of 
ApcmNLS/mNLS mice compared to Apc+/+ mice. In these same tissues, Hath 1, a gene down-
regulated in response to a canonical Wnt signal showed lower expression throughout the 
intestinal epithelia of ApcmNLS/mNLS mice compared to Apc+/+ mice. BTEB2, a gene 
reportedly up-regulated in response to non-canonical Wnt signal, showed no expression 
alterations in jejunum or ileum from ApcmNLS/mNLS mice compared to Apc+/+ mice. 
Unexpectedly, in colon tissue, BTEB2 expression was higher in both ApcmNLS/mNLS and 
ApcmNLS/+ mice compared to Apc+/+ mice.
Increased proliferation in intestinal epithelia of ApcmNLS/mNLS mice
Given the increased expression of c-Myc and Cyclin D1 in intestines of ApcmNLS/mNLS 
mice, we expected to find an accompanying increase in proliferation. To evaluate epithelial 
cell proliferation in intestinal tissue, mice were analyzed 4 hours after injection with the 
thymidine analogue EdU. Crypts from jejunum, ileum and colon each displayed 
significantly more proliferating cells in ApcmNLS/mNLS mice than in ApcmNLS/+ and Apc+/+ 
mice (Fig. 5).
Enhanced polyp formation in intestines of ApcMin/mNLS mice
Mice with germline truncating mutations in Apc occasionally display a few adenomatous 
polyps in the colon, with the great majority of polyps found in the small intestine (46). 
Therefore, we targeted both colon and small intestine for our initial phenotypic analysis. No 
adenomatous polyps of the small intestine were identified in any of the ApcmNLS/+ mice 
from generations N1-N4 analyzed for intestinal lesions (n=33). One dysplastic colon polyp 
was found in an ApcmNLS/mNLS mouse (Fig. 6A–D). A polyp was also found in the stomach 
of another ApcmNLS/mNLS mouse (generation N11).
The few intestinal lesions observed in the ApcmNLS/mNLS mice left open the possibility that 
nuclear Apc participates in polyp suppression. To examine this more efficiently, congenic 
ApcmNLS/+ mice were bred with ApcMin/+ mice. Polyp number, size and distribution were 
compared in 14-week old progeny ApcMin/+ and ApcMin/mNLS mice. Significantly more 
polyps were found in the jejunum and the ileum of ApcMin/mNLS mice than in ApcMin/+ mice 
(Fig. 7A and supplementary Fig 3). There were only a few polyps observed in any colon 
tissue with no significant variation between ApcMin/+ and ApcMin/mNLS mice (Fig. 7B and 
supplementary Fig 3). Even fewer polyps were observed in the stomach and duodenum 
tissues, but the average polyp number was slightly larger in ApcMin/mNLS mice than in 
ApcMin/+ mice (Fig. 7B and supplementary Fig 3). Combining results from the entire G.I. 
tissue, we observed nearly twice as many polyps in ApcMin/mNLS mice than in ApcMin/+ 
Zeineldin et al. Page 5













mice (Fig. 7C). These results suggest that the ApcmNLS enhances polyp initiation or 
development in the ApcMin mouse model. Furthermore, the average polyp size was 
significantly larger in jejunum and ileum tissue of ApcMin/mNLS mice compared to ApcMin/+ 
mice (Fig. 7D). Collectively, the results from this study suggest that nuclear Apc contributes 
to a tumor suppressor phenotype.
Increased proliferation in intestinal polyps from ApcMin/mNLS mice
To begin to explore the mechanism of enhanced polyp formation in ApcMin/mNLS mice, we 
examined cellular proliferation and β-catenin distribution in polyps from ApcMin/mNLS and 
ApcMin/+ mice. Strong nuclear β-catenin staining was observed in polyps from both 
ApcMin/mNLS and ApcMin/+ mice (Fig. 7F, a–d). In contrast, β-catenin appeared 
predominantly at the cell-cell junctions of normal intestinal cells from both ApcMin/mNLS 
and ApcMin/+ mice. Although nuclear β-catenin was prevalent in both ApcMin/mNLS and 
ApcMin/+ polyps, not every cell with nuclear β-catenin was positive for proliferation marker 
Ki-67 (Fig. 7F, e–h). Closer examination of Ki-67-positive cells revealed that polyps from 
ApcMin/mNLS mice had significantly more proliferating cells than polyps from ApcMin/+ 
mice (Fig. 7E). Combined with the observation that there were more polyps and these 
polyps were larger in intestines of the ApcMin/mNLS mice than in the ApcMin/+ mice (Fig. 7 
A–D), it is likely that contributions of nuclear Apc to regulation of cellular proliferation 
impacts tumor suppression in this newly developed model.
Discussion
Nuclear APC has been observed in cultured cells, in cells of various model organisms and in 
human tissues (29). Roles for nuclear APC in DNA repair and replication as well as Wnt 
signal regulation have been proposed (13, 15, 32, 37, 38, 43). However, to date, 
experimental manipulation of nuclear APC has been confined to cultured cells. In this 
report, we describe a new mouse model with mutations "knocked-in" the Apc gene which 
inactivate the two canonical Apc NLSs (51). To our knowledge, the ApcmNLS/mNLS model is 
the first mouse generated to specifically inhibit nuclear import of any protein by knock-in 
mutations that target and inactivate an NLS. ApcmNLS/mNLS mice were viable and displayed 
increased proliferation of epithelia throughout the small intestine and colon. Epithelia from 
jejunum, ileum, and colon also exhibited increased canonical Wnt signaling as evidenced by 
increased expression of genes up-regulated by canonical Wnt signal (cyclin D1, c-myc and 
Axin 2) and decreased expression of genes down-regulated by canonical Wnt signal (Hath 
1). This increased Wnt signaling could explain the enhanced proliferation observed in these 
same tissues. Although only occasionally observed in ApcmNLS/mNLS mice, polyps in 
jejunum and ileum were significantly more abundant and larger, with increased proliferative 
index in ApcMin/mNLS mice compared to ApcMin/+ mice, implicating nuclear Apc in 
suppression of polyp formation.
The best characterized role for nuclear APC involves negative regulation of Wnt signaling 
(32, 43). Based on studies performed in cultured cells, it was proposed that nuclear APC 
binds to nuclear β-catenin, sequestering it from a complex with activated TCF/LEF (32) and 
mediating β-catenin export to the cytoplasm (13, 33, 39). There is also evidence that APC 
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can interact with transcriptional corepressor CtBP (43), resulting in inhibition of TCF/LEF-
mediated transcription and dampening of a Wnt signal (30). Our data indicate that Wnt 
signaling is up-regulated in ApcmNLS/mNLS mice, supporting a role for nuclear Apc as a 
negative regulator of Wnt signaling. Of note, in this study, the alterations in Wnt gene 
expression occurred without increased β-catenin levels. This finding supports an alternate 
mechanism that does not require destruction of β-catenin for Apc to elicit dampening of a 
Wnt signal. We also found that cells from ApcmNLS/mNLS mice had no increase in nuclear β-
catenin, consistent with a role for nuclear Apc in transport of transcription repressors to the 
β-catenin/TCF/LEF complex and/or sequestration of nuclear β-catenin. However, as cells 
from ApcmNLS/mNLS mice displayed some nuclear Apc, we can not fully exclude the 
possibility that Apc also plays a role in nuclear export of β-catenin.
Some Wnt target genes such as c-Myc and cyclin D1 are associated with cell cycle 
progression (12, 47). If nuclear Apc down-regulates Wnt signaling, then reduced nuclear 
Apc should lead to enhanced TCF/LEF-mediated transcription, increased expression of c-
Myc and cyclin D1, and consequently, more proliferation. Our finding that intestinal 
epithelia of ApcmNLS/mNLS mice display increased Wnt signaling, including up-regulation of 
c-Myc and cyclin D1, and increased proliferation further supports a role for nuclear Apc in 
control of cell cycle progression.
The mutations introduced into Apc were minimal, and we expected the phenotype of 
ApcmNLS/mNLS mice would be more subtle than that of previous Apc mouse models which 
express truncated Apc proteins. The combined six amino acid substitutions in Apc NLS1 
and NLS2 do not appear to impact Apc binding to β-catenin or axin (supplemental Fig. 1). 
Apc and β-catenin levels in epithelia isolated from either jejunum or ileum were similar in 
ApcmNLS/mNLS and Apc+/+ mice (Fig. 3). Therefore, the alteration in expression of 
canonical Wnt targets seen in these tissues did not likely result from compromised β-catenin 
degradation and it is likely that the observed phenotypes of ApcmNLS/mNLS mice result from 
compromised nuclear import of Apc.
Nuclear Apc entry was severely compromised, but not entirely eliminated in MEFs from 
ApcmNLS/mNLS mice (Fig. 2). The two Apc NLSs that were inactivated in our mouse model 
are each classic monopartite NLSs, which bind to importin-α in the cytoplasm to target 
protein transport through the nuclear pore (5, 11). The continued presence of some Apc in 
the nuclei of MEFs isolated from ApcmNLS/mNLS mice supports the existence of alternative 
processes by which Apc may gain nuclear access. In the mouse model described here, the 
two canonical NLSs are eliminated, but the Armadillo repeat domain which has been 
previously implicated in nuclear import of APC remains intact (9). In human polyp tissue 
and colon cancer cell lines, the Armadillo repeat domain has been proposed to mediate 
nuclear entry of truncated forms of APC that lack the canonical NLSs (1, 6). Moreover, the 
15-amino acid repeat region of APC (aa. 959–1338) can facilitate nuclear import of a fused 
green fluorescent protein (49). It is possible that one or both of these auxiliary Apc domains 
binds to nuclear import machinery directly, or may allow Apc binding to other proteins that 
are able to facilitate nuclear import or retention of Apc.
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The most surprising result from this study was that ApcMin/mNLS mice had nearly twice as 
many polyps as ApcMin/+ mice (Fig. 7C). Furthermore, polyps from ApcMin/mNLS mice were 
larger on average than those from ApcMin/+ mice (Fig. 7D). Together, these observations are 
consistent with a role for nuclear Apc in suppression of polyp initiation or progression. 
ApcmNLS/mNLS mice showed increased proliferation and Wnt signaling, either of which 
would be expected to enhance polyp formation. A recent report showed an association of 
Wnt target gene up-regulation with increased intestinal adenomas in Apc1322T/+ mice (36). It 
is also possible that the observed increase in polyp number and size might result from a role 
for nuclear Apc in suppressing polyp progression, once the polyp is initiated. In this 
scenario, polyps would initiate at the same rate in ApcMin/mNLS and ApcMin/+ mice, but 
would more rapidly grow large enough for detection in the ApcMin/mNLS mice. Our finding 
of increased proliferation in polyps from ApcMin/mNLS mice compared to ApcMin/+ mice 
does not distinguish between these two scenarios, but does implicate nuclear Apc regulation 
of cell proliferation as a contributing factor to tumor suppression.
In the current study, three separate parameters each showed a response in the colon distinct 
from that seen in the jejunum or ileum. Epithelia from jejunum or ileum did not display 
elevated levels of either Apc or β-catenin (Fig. 3). In contrast, colon epithelia displayed Apc 
and β-catenin protein levels that were significantly higher in ApcmNLS/mNLS mice compared 
to Apc+/+ mice. This finding confirms that high levels of Apc do not always result in 
constitutive β-catenin degradation. Changes in expression of Wnt target genes were 
consistent with elevated canonical Wnt signaling in jejunum, ileum and colon tissues from 
ApcmNLS/mNLS mice compared to Apc+/+ mice (Fig. 4). However, BTEB2, a gene not 
regulated by canonical Wnt signaling, was unchanged in jejunum and ileum, but was 
elevated in colonic epithelial cells from ApcmNLS/mNLS mice compared to Apc+/+ mice. 
Finally, unlike small intestinal tissue, colon tissue from ApcMin/mNLS mice did not show 
elevated polyp size or multiplicity compared to ApcMin/+ mice (Fig. 7B, 7D). Why do the 
colon and small intestine tissues show distinct responses to manipulation of Apc NLSs? We 
speculate that this variability might result from potential alternate feedback responses 
(chromosomal instability, apoptosis, survival) dependent on tissue type. Moreover, colon 
tissue lacks villi, performs a distinct function and maintains a different flora than the small 
intestine. Although not completely understood, humans and rats with germline APC 
mutations are prone to colon polyps, whereas mice with similar Apc mutations have polyps 
predominantly in the small intestine. Any of these factors might contribute to the differences 
seen in colon and small intestinal tissue from ApcmNLS mice. Future studies utilizing the 
novel ApcmNLS/mNLS model might offer clues to some of these longstanding puzzles in Apc 
biology.
In summary, the novel ApcmNLS/mNLS mouse model contains a subtle alteration that 
inactivates both Apc NLSs. Increased expression of Wnt targets and increased proliferation 
in intestines of adult ApcmNLS/mNLS mice implicate nuclear Apc in control of cellular 
proliferation and Wnt signaling. The finding of increased numbers and size of small 
intestinal polyps in ApcMin/mNLS mice compared with ApcMin/+ mice implicates nuclear 
Apc in tumor suppression. Future studies of this novel mouse model will elucidate nuclear 
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Apc contributions to other cellular events critical for tissue homeostasis, such as DNA 
repair, transcription regulation and cell cycle progression.
Materials and methods
Creating the Gene Replacement Vector
The homologous sequences of DNA used for the targeting construct were obtained from a 
lambda phage library of genomic DNA isolated from 129 mouse ES cells (generously 
provided by Kirk Thomas and Mario Capecchi, University of Utah). This library was 
screened for fragments of Apc containing the two primary Apc nuclear localization signals 
(NLSs). Following identification of an Apc NLS-containing plaque by hybridization to a 
radioactive probe, a 14 kb stretch of mouse genomic DNA (Apc exons 14, 15 and 
surrounding introns) was isolated from the phage and inserted into the pBluescript KSII+ 
vector (Stratagene). An EcoRI fragment containing both Apc NLSs was subcloned into the 
pUC19 vector. Mutations that inactivated each NLS and introduced novel restriction sites 
were inserted by PCR mutagenesis (Figure 1B). A second pUC19 vector was modified to 
destroy its EcoRI restriction site and introduce Nhe I and Not I sites. An 11,537 bp region of 
Apc (NheI/NotI) was subcloned into this modified vector. The EcoRI fragment of Apc 
containing wildtype NLSs was replaced by the same fragment with mutant NLSs. Using 
restriction sites for KpnI and AflII in the noncoding region 3’ to Apc exon 15, a tACE-Cre-
Neor cassette, flanked by two LoxP sites was introduced into the pUC19 vector containing 
the Apc gene fragment with mutant Apc NLSs. This tACE-Cre-Neor cassette included a 
neomycin resistance gene (Neor) driven by the promoter for RNA polymerase II and was 
linked to a gene encoding Cre recombinase under control of the testes-specific murine 
angiotensin-converting enzyme (tACE) promoter (2). The HSV thymidine kinase gene 
controlled by the phosphoglycerate kinase (PGK) promoter was inserted upstream of the 
Apc homology sequences in the pUC19 vector to create the 19,947 bp targeting vector 
(Figure 1A).
Electroporation into Embryonic Stem Cells
The targeting construct DNA was cleaved with Not I restriction endonuclease to linearize at 
a unique site 3’ of the region homologous to Apc. Digestion with Not I was followed by two 
phenol/chloroform extractions before the linearized gene replacement vector was 
electroporated into R1 mouse embryonic stem cells (27) at the Transgenic and Gene-
Targeting Institutional Facility at The University of Kansas Medical Center. Cells were 
selected for growth in 300µg/mL G418 (Cellgro) and 2µM ganciclovir (Roche). Following 
8–10 days of culture in selective media, each surviving colony was picked and expanded 
into two separate wells. DNA was isolated from one well for genotype analysis and the cells 
in the remaining well were frozen in 96-well plates for injections.
Screening and Verifying Targeted ES cell lines
Identification of ES cell lines containing mutations in both Apc NLSs was accomplished 
using a two-step PCR screen and the following primer sets: wildtype Apc NLS1 forward and 
NLS2 reverse, wNLS1fw (5’-CTA AGA AAA AGA AGC CTA CTT CAC) and wNLS2rv 
(5’-GGC CTT TTC TTT TTT GGC ATG GC); mutant Apc NLS1 forward and NLS2 
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reverse, mNLS1fw (5’-GCA GCC GCG GCA CCT ACT) and mNLS2rv (5’-TTG AAG 
GCC TTT TTG CGG CC) (Figure 1C). To identify homologous cassette insertion at the 3’ 
end, a primer annealing to DNA in the LoxP/tACE promoter region of the tACE-Cre-Neor 
cassette (5’-CCT GGC CCA TGG AGA TCC AT) was used with a primer annealing to 
genomic Apc 3’ of the targeting construct (5’-CAT ACC ACC CAC CAT CCC TA) or with 
a primer annealing to the 3’ end of the targeting construct (TCT CCC ATT GCT TAT GGC 
AAC) as a positive control (Figure 1H). Cell lines were also screened for correct 
incorporation of the 5’ end of the targeting construct using PCR. The reverse primers 
wNLS2rv and mNLS2rv were used in conjunction with the following primer that anneals to 
a region of genomic DNA upstream of the 5’ end of the targeting construct: (5’-AAA TTG 
AAC TCA GGA CCT TCT C) (Figure 1F). PCR products digested with SstII produced a 
6100bp DNA product if mutant Apc NLS1 was present (Figure 1G). Each cell line with 
correct homologous recombination was further evaluated by determining the karyotype of 
40–50 cells.
Generation of Chimeric Mice
For the generation of chimeric mice, ApcmNLS/+ ES cells were injected into C57BL/6J 
blastocysts at the Gene Targeting and Transgenic Facility at the University of Virginia. Male 
chimeric mice that carried the mutant copy of Apc were bred to C57BL/6J females originally 
obtained from The Jackson Labs (Bar Harbor, Maine). Black progeny were culled and 
agouti colored progeny were genotyped using tail DNA isolated following a protocol from 
The Jackson Laboratory (http://www.jax.org/imr/tail_nonorg.html) and PCR to screen for 
the presence of the mutant nuclear localization sites. Verification of selection cassette loss in 
the ApcmNLS/+ progeny was conducted using PCR with the following primers: forward 
primer, 5’-TCG GCC ATT GAA CAA GAT GGA-3’ and reverse primer, 5’-ATT CGC 
CGC CAA GCT CTT CA-3’ (Figure 1E).
Mouse Husbandry
Mice were maintained in the Animal Care Unit at the University of Kansas according to 
animal use statement number 137-01. The research complied with all relevant federal 
guidelines and institutional policies. The chimeric mice were bred with C57BL/6J mice from 
The Jackson Labs (Bar Harbor, Maine). ApcmNLS/+ progeny from the original mating of 
male chimeric mice with female C57BL/6J mice were repeatedly backcrossed to the inbred 
C57BL/6J mice 10–18 times to generate a line that was considered to be congenic (N10-
N18). Detailed records including the date of birth, lineage, coat color, sex, genotype and 
date of sacrifice were maintained for each individual mouse. For the survival curve, N1 male 
and female ApcmNLS/+ mice were bred and F1 progeny were housed with same sex siblings 
for the duration of the study (n=18 for Apc+/+; 19 for ApcmNLS/+; and 18 for ApcmNLS/mNLS 
mice). Cause of death for mice in the survival study was not determined because mice were 
allowed to die naturally and thus most were not collected for many hours after their death. 
Mice were fed ad libitum with Purina Lab Diet 5001 and were housed in cages in adjoining 
animal rooms. Congenic mice weighed at different times between ages 6 and 14-weeks 
showed no significant differences comparing Apc+/+ and ApcmNLS/mNLS mice. ApcMin/+ 
mice were purchased from The Jackson Labs and were maintained by breeding males with 
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C57BL/6J females. ApcMin/mNLS mice were generated by breeding male ApcMin/+ mice 
(from Jackson Labs) with congenic (N10-N15) female ApcmNLS/+ mice.
Mouse genotyping
After weaning, mouse pups were tagged with a metal ear tag or by injection of an 
implantable electronic transponder (Bio Medic Data Systems Inc.) into the subcutaneous 
space above the shoulders. The Apc genotype of each mouse pup was determined using 
isolated tail DNA and PCR to screen for the presence of the wild-type and mutant NLS 
coding sequences using the following primers: forward, 5’-
TAGTGATGCGGTGAGTCCAA-3’ and reverse, 5’-ACCAAGTCCAACAAGCATCC-3’. 
Reaction conditions were: 94°C for 5 min., 35 cycles of 94°C for 1 min., 54°C for 1 min., 
68°C for 1 min., final 3 min. at 68°C. PCR products (295 bps) were cut with SacII 
restriction enzyme. The restriction enzyme does not cut the wildtype allele but cuts the 
mutant allele into 2 fragments of 235 and 60-bp (Supplemental Fig. 4). The ApcMin allele 
was detected using the standard PCR protocol published by the Jackson Laboratories (http://
jaxmice.jax.org).
Analysis of gross and microscopic pathology, polyp measurement
The gross and cellular histology of intestinal tissues were examined in the N1-N13 
generations of ApcmNLS mice and in fourteen-week old ApcMin/+ mice and ApcMin/mNLS 
mice. For each mouse, GI tract from the stomach to the anal canal was dissected, opened 
longitudinally and fixed in 10% buffered formalin. Using a dissecting microscope, an 
investigator blind to the animal’s genotype examined the intestinal luminal surface for any 
irregularities and polyps. Regions of tissue with abnormalities were recorded, removed from 
the surrounding tissue and stored in 10% buffered formalin. Tissue that appeared grossly 
abnormal was sent for pathologic evaluation. Intestinal polyps were located and diameter 
measured with the aid of a dissection microscope (Leica, MZ8) equipped with an eyepiece 
graticule and calibrated to a 50-mm scale stage micrometer with 0.1 and 0.01-mm 
graduation. Fourteen-week old ApcMin/mNLS and ApcMin/+ mice were analyzed for this 
study.
Evaluation of proliferation in intestinal epithelia
For proliferation analysis, congenic mice were injected with EdU, and intestinal tissue 
prepared and stained as described (28). Briefly, at the time of sacrifice, mouse small and 
large intestines were removed and opened lengthwise. The colon, and proximal, middle and 
distal regions of the small intestine were individually rolled as described (19) to form 
multiple “Swiss Rolls”. The sections of rolled colon and small intestine were incubated in 
fixative [4% paraformaldehyde, 0.1% triton X-100, in PBS] on ice for 1 hour, rinsed in PBS 
and incubated in 2.5 M sucrose at 4°C overnight. After PBS rinse, rolled tissue sections 
were frozen in OCT tissue freezing media (VWR) at −20°C. Sections were sliced 
immediately or stored at −80°C. Tissue cryosections (7µm) were made using a Leica 
CM1900 cryotome and adhered to glass slides coated with histomount (Invitrogen) for 
immunohistochemistry. Slides were air dried for approximately 1 min. then tissue slices 
were permeabilized in 70% methanol before staining for EdU as described (40). For each 
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tissue in each genotype, 50–100 crypts were analyzed for proliferation by scoring the 
number of EdU-positive cells and the total cell number by DAPI stain in a crypt cross 
section. Samples were coded so that analysis could be performed by a trained observer blind 
to the study parameters. Data from 3 mice of each genotype were collected to determine 
proliferation in the various intestinal tissues. Only crypts with 40 or more cells in cross 
section were scored.
Immunohistochemistry of intestinal epithelia and polyps
Tissues were fixed in 10% saline-buffered formalin 16–20 hr then stored in 70% ethanol. 
Tissues were embedded in paraffin and sectioned at 6-µm. Immunohistochemistry for β-
catenin and Ki-67 was performed using the Histomouse kit® (Invitrogen, Cat# 95–9541) 
according to the manufacturer’s protocol and with mouse monoclonal anti-β-catenin 
antibodies (1:100, BD Biosciences, Cat# 610153) and rat anti mouse Ki-67 antibodies (1:20, 
Dako, Cat# M7249). Tissues were coded allowing the analysis to be performed by an 
observer blind to the tissue genotype. Normal appearing Jejunum, Ileum and colon tissues 
from at least 3 mice of each genotype (Apc+/+, ApcmNLS/+, and ApcmNLS/mNLS) were 
examined for β-catenin localization. In addition, 6 polyps from 4 ApcMin/+ mice and 7 
polyps from 3 ApcMin/mNLS mice were examined for β-catenin localization. After surveying 
the entire length of tissue for β-catenin localization, the average distribution was recorded 
and representative images captured using 20X and 40X objectives. The polyps were also 
scored for Ki-67 by counting Ki-67 positive cells per field at 40X magnification. Three 
fields were photographed and scored for each polyp. The p-values for all proliferation 
studies were calculated using unpaired, two-tailed t-tests and GraphPad Prism software.
Isolation of mouse intestinal epithelial cells
Isolation of intestinal epithelial cells was performed with modifications to a previous 
protocol (50). Immediately after sacrifice, small and large intestines were removed from 
congenic mice, opened lengthwise and rinsed with cold PBS. Tissue was incubated in 0.04% 
sodium hypochlorite for 15 min. on ice and then rinsed in cold PBS. The colon and small 
intestine were then incubated on ice for 15 min in individual 15mL conical tubes containing 
EDTA/DTT solution (1.5–3mM EDTA and 0.5mM DTT in PBS). EDTA/DTT solution was 
poured off and replaced with cold PBS. Tubes were shaken forcefully for 10 sec. to release 
the epithelial cells from the underlying tissue. The intestinal tissue was removed and placed 
in a fresh 15mL conical tube of EDTA/DTT solution, and the process was repeated two 
additional times. The released epithelial cells were collected by centrifugation at 700xg for 5 
min. at room temperature. Pellets of the colon epithelia from all three rounds of extraction 
were resuspended in PBS with protease inhibitors and combined into one sample. Because 
the surface area of the small intestine is significantly greater than that of the colon, there was 
no need to combine the epithelial tissue from the replicate extractions. The small intestinal 
epithelial cells from the second round of extraction were used in the experiments described 
here. Cell pellets were lysed in Reporter Lysis Buffer (Promega) with protease inhibitors 
[aprotinin, leupeptin and pepstatin each at 10 µg/ml and 1 mM PMSF] and briefly sonicated. 
Samples were boiled after addition of Sample Buffer [3X Sample Buffer: 6% w/v Sodium 
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Dodecyl Sulfate, 30% Glycerol, 150mM Tris pH 6.8, ~0.2mg/mL Bromophenol Blue] and 
resolved by SDS-PAGE before transfer to nitrocellulose membranes.
Immunoblot analysis of Apc and β-catenin in intestinal tissue and MEF fractionation
Immunoblots were processed as described (49). Membranes were probed with the following 
primary antibodies diluted as indicated in 5% nonfat dry milk/TBST: rabbit anti-APC M2 
(1:3000,(48)), mouse anti-β-catenin (1:2000, BD Biosciences, Cat# 610153), mouse anti-α-
tubulin (1:50, Developmental Studies Hybridoma Bank), rabbit anti-fibrillarin (1:1000, 
ab5821 AbCam), β-actin (1:2000,Sigma). The following secondary antibodies were diluted 
as indicated: HRP goat anti-mouse (1:10–25,000, Zymed) and HRP goat anti-rabbit (1:10–
25,000, Bio-Rad). Blots were developed using Western Lightning Chemiluminescence 
Reagent Plus (PerkinElmer) or SuperSignal West Femto Maximum Sensitivity Substrate 
(Pierce) and a Kodak Image Station 4000R. Band analysis was conducted using Kodak ID 
Image Analysis Software with protein levels first normalized to β-actin and then values for 
the Apc+/+ samples set to 1. The p-values were calculated using Mann-Whitney 
nonparametric test. MEFs of each genotype were isolated from congenic (N10-N18) mice on 
three independent occasions following the protocol as described (26). Independently isolated 
early passage MEFs were subjected to fractionation in five independent experiments as 
described (31). Nuclear Apc and β-catenin were calculated based on the band intensity in the 
nuclear fraction divided by the intensity of the nuclear plus the cytoplasmic bands. The p-
values were calculated using unpaired, two-tailed t-tests and GraphPad Prism software.
Analysis of mRNA using real time RT-PCR
For preparation of RNA, 200-µl of suspended epithelial cells were added to 1-ml Trizol® 
(invitrogen) and tubes were stored at −80°C until used. RNA extraction was performed 
using Trizol® according to the manufacturer’s protocol. For making cDNA, 1µg total RNA 
was incubated for 1 hour at 42°C with the cDNA reaction mix containing 1 mM dNTPs, 1µg 
random hexamer primers (NEB), 1X M-MLuV enzyme buffer (NEB) and 200 units M-
MLuV RT enzyme (NEB). The reverse transcriptase enzyme was then inactivated by 
heating at 95°C for 5 minutes. Quantitative PCR was carried out for c-Myc, Axin2, Cyclin 
D1, BTEB2, and Hath1 cDNA from the mouse intestinal epithelial cells. The cDNA of the 
house keeping gene HGPRT was used as an internal control. Table I shows the primers used.
PCR reactions were performed using a DNA engine Opticon 2 system (MJ research) with 
SYBR green detection system. The total reaction volume was 25µl containing 1X 
DyNAmo™ HS SYBR® Green qPCR Kit (Finnzymes), 15 picomoles of each primer and 3 
µl of 1:2.5 diluted cDNA. Each reaction was done in triplicate and repeated three times. The 
reaction condition was initial denaturation at 95°C for 15 minutes followed by 40 cycles of 
denaturation at 94°C for 20 seconds, annealing at 54°C for 30 seconds and extension at 72°C 
for 30 seconds. The fluorescence was measured at the end of every cycle and a melting 
curve was analyzed between 40°C and 95°C with 0.2°C increment. Samples were only 
included in the analysis if the melting curve was a single peak at the expected temperature. 
Average ΔC(T) was calculated for different genotypes relative to the house keeping gene 
transcript while ΔΔC(T) of Wnt target cDNA for ApcmNLS/+ and ApcmNLS/mNLS was 
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calculated relative to the Apc+/+ mice. The p-values were calculated using Mann-Whitney 
nonparametric test and GraphPad Prism software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Generation of ApcmNLS/+ mouse ES cell lines
(A) Schematic representation of Apc NLS targeting vector. Drawn roughly to scale, the 
vector includes Apc exons 14 and 15 (dark blue), with surrounding introns (light blue). A 
Neomycin resistance gene (Neor, purple) inserted in the final Apc intron is flanked by Lox P 
sites (green) that will facilitate its excision when expressed in the testes where the tACE 
promoter (murine angiotensin-converting enzyme) drives expression of Cre recombinase. 
The herpes simplex virus thymidine kinase gene (TkHSV) allows negative selection of 
homologous recombinant ES cell clones. (B) Mutations in Apc NLS1 and NLS2 result in 
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amino acid substitutions inactivating the nuclear localization signals and also introduce 
unique restriction enzyme sites for screening purposes. (C) Analysis of ES cell lines with 
PCR using primers specific for the wildtype (wt) or mutant (m) Apc NLS allowed 
identification of 107 lines with both Apc NLS1 and NLS2 mutated. (D) Samples 2 and 4 in 
the gel image shown each have both Apc NLSs mutated. PCR reaction without template 
DNA (neg). (E) Excision of the Ace-Cre-Neor selection cassette was verified in N2 
ApcmNLS/+ mice using PCR with primers specific for Cre. Genomic DNA isolated from wild 
type (WT) and ApcmNLS/+ ES cell lines was used as a negative and positive control, 
respectively, for the Cre primer PCR (Cr). PCR using primers specific for wild type 
sequence (wt) and mutant sequence (m) confirmed that the mouse analyzed was ApcmNLS/+ 
and demonstrated genomic DNA quality sufficient for PCR analysis. (F) Scheme to 
determine correct integration of the 5’ and 3’ ends of the targeting vector. (G) Correct 
integration of the 5’ end of the targeting vector was established by PCR analysis using a 
primer specific for mutant Apc NLS2 with a second primer that recognizes genomic 
sequence outside the targeting construct and upstream of a correctly integrated vector. 
Products of this PCR reaction were digested with Sst II to confirm integration of mutant Apc 
NLS1. (H) PCR analysis using a primer unique to the targeting construct with a second 
primer that recognizes genomic sequence outside the targeting construct and downstream of 
a properly integrated vector allowed identification of 8 recombinant ES cell lines that had 
correctly integrated the 3’ end of the targeting vector (samples 1 and 2). TC, targeting vector 
control product is ~ 1800 bp if targeting vector is integrated into genomic DNA. AI, Apc 
integrated product is ~ 2500 bp if targeting vector is properly inserted into the Apc gene.
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Figure 2. Reduced nuclear Apc levels in MEFs from ApcmNLS/+ and ApcmNLS/mNLS mice
(A) Mouse Embryonic Fibroblasts (MEFs) isolated from congenic Apc+/+, ApcmNLS/+ and 
ApcmNLS/mNLS mice were subjected to fractionation followed by immunoblot. A single blot, 
probed for Apc, β-catenin, tubulin (cytoplasmic marker) and fibrillarin (nuclear marker) is 
shown. (B) Apc band intensities were determined and results from five independent 
fractionation experiments performed on three different isolations of MEF cells are presented 
as the fraction of the total Apc protein in the nucleus ± SEM. ApcmNLS/mNLS MEFs 
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displayed significantly less nuclear Apc than Apc+/+ MEFs (p = 0.012). (C) β-catenin 
distribution, determined as in (B), was similar in all MEF lines.
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Figure 3. Apc and β-catenin levels in intestinal epithelia from ApcmNLS/+ and ApcmNLS/mNLS 
mice
Epithelial cells were isolated from three intestinal segments (jejunum, ileum and colon) of 
congenic Apc+/+, ApcmNLS/+ and ApcmNLS/mNLS mice. Proteins from whole cell lysates 
were resolved using SDS-PAGE. Immunoblots were probed for Apc, β-catenin and β-actin 
which served as a loading control (top panels). Band intensities were determined for four 
samples from each genotype and are presented as average band intensity ± SEM relative to 
β-actin and normalized to the Apc+/+ sample which was set to 1 (middle and bottom panels). 
Apc and β-catenin levels appeared comparable in epithelial cells isolated from jejunum and 
ileum of mice of each genotype. Using the Mann-Whitney nonparametric test, colon tissue 
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from ApcmNLS/mNLS mice showed significantly higher levels of both Apc (p = 0.017) and β-
catenin (p = 0.01) than colon tissue from Apc+/+ mice.
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Figure 4. Elevation of Wnt target gene expression in ApcmNLS/mNLS mice
Epithelial cells were isolated from three intestinal segments (jejunum, ileum and colon) of 
congenic Apc+/+, ApcmNLS/+ and ApcmNLS/mNLS mice. For each sample, mRNA levels of 
three genes up-regulated by canonical Wnt signaling (cMyc, Axin2, and Cyclin D1), one 
gene which is down-regulated by canonical Wnt signaling (Hath1), and one gene which is 
not regulated by canonical Wnt signaling (BTEB2), each normalized to HGPRT 
(housekeeping gene, control) were determined using real time quantitative RT-PCR. Results 
from 4–6 mice are presented as average mRNA level relative to that found in the Apc+/+ 
sample ± SEM. p values < 0.05 as calculated using the Mann-Whitney nonparametric test, 
are indicated with *. Levels of Hath 1 mRNA in jejunum samples from ApcmNLS/mNLS mice 
were around the lower limit of detection, precluding calculation of a ΔΔC(T) for some 
samples.
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Figure 5. Increased epithelial cell proliferation in intestines of ApcmNLS/mNLS mice
Representative images of crypts from EdU-labeled intestinal tissue isolated from Apc+/+, 
ApcmNLS/+ and ApcmNLS/mNLS mice with white line denoting crypt border (left panels). 
Dapi staining allowed identification of cell nuclei. Scale bar, 10 µm. Right panels, the 
average number of EdU-positive cells per crypt cross section normalized to the total crypt 
cell number is presented with error bars indicating SEM. Samples were collected from 3 
mice of each genotype. Top, jejunum tissues showed a significant increase in proliferation 
in ApcmNLS/mNLS mice compared to Apc+/+ mice (p < 0.0001). Middle, ileum tissues 
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showed a significant increase in proliferation in ApcmNLS/mNLS mice compared to Apc+/+ 
mice (p < 0.05). Bottom, colon tissues showed a significant increase in proliferation in 
ApcmNLS/mNLS mice compared to Apc+/+ mice (p < 0.0001).
Zeineldin et al. Page 26













Figure 6. Polyps in ApcmNLS/mNLS mice
(A) Low power magnification of lesion in colon of ApcmNLS/mNLS mouse. scale bar, 1 mm. 
(B) Same lesion with higher magnification of region outlined by white box in (A) showing 
epithelial atypia. Nuclei are enlarged with loss of polarization. scale bar, 100 µm. (C) Higher 
power magnification of region with cell atypia from (B) showing enlarged nuclei. scale bar, 
25 µm. (D) A progression of atypia is shown in the same tissue (approximate area shown in 
black box in (A)) from lower right with more polarized nuclei to upper left with enlarged 
non-polarized nuclei. A representative dysplastic crypt is outlined in white. scale bar, 50 µm.
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Figure 7. ApcMin/mNLS mice have more and larger polyps than ApcMin/+ mice
Polyps were identified and measured in fourteen-week old ApcMin/+ (n=12) and 
ApcMin/mNLS (n=8) mice. (A) Results presented as average polyp number per mouse ± SEM 
indicate significantly more polyps in the jejunum (p = 0.035) and the ileum (p = 0.0002) of 
ApcMin/mNLS mice compared to ApcMin/+ mice. (B) Polyps were also identified in the colon, 
stomach, and duodenum but showed no statistically significant differences in ApcMin/mNLS 
and ApcMin/+ mice. (C) Results from all G.I. tissues combined (jejunum, ileum, colon, 
stomach, duodenum) indicate significantly more polyps in ApcMin/mNLS compared to 
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ApcMin/+ mice (p = 0.0021). (D) Diameters of all polyps are shown as a box and whisker 
plot. Polyps in both jejunum and ileum were significantly larger in ApcMin/mNLS mice than 
in ApcMin/+ mice (p < 0.0001). (E) Significantly more proliferation, as determined by Ki-67 
expression, was observed in polyps isolated from the ileums of ApcMin/mNLS mice than 
ApcMin/+ mice (p = 0.0003). (F) A tissue section of polyp from ApcMin/+ or ApcMin/mNLS 
mice stained for β-catenin (a–d) with subsequent section stained for Ki-67 (e–h). Scale bar 
in (a) is 200 µm and also corresponds to (c), (e), and (g). Panels (b) (d) (f) and (h) show 
higher power magnifications of regions indicated with black boxes in the previous panels, 
with 50 µm scale bar shown in (b).
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Table I
primers used for quantifying canonical and non-canonical Wnt targets in mouse intestinal epithelial cells
Gene Forward primer Reverse primer
c-Myc 5’- TCCTGTACCTCGTCCGATTC-3’ 5’- GGTTTGCCTCTTCTCCACAG-3’
Axin2 5’- TGTGAGATCCACGGAAACAG-3’ 5’- CTGCGATGCATCTCTCTCTG-3’
Cyclin D1 5’- TTGACTGCCGAGAAGTTGTG-3’ 5’- AGGGTGGGTTGGAAATGAAC-3’
Hath1 5’-ACATCTCCCAGATCCCACAG-3’ 5’-ACAACGATCACCACAGACCA-3’
BTEB2 5’-CTCCGGAGACGATCTGAAAC-3’ 5’-GAACTGGAGGGAGCTGAGG-3’
HGPRT 5’- TGCTCGAGATGTCATGAAGG-3’ 5’- TATGTCCCCCGTTGACTGAT-3’
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